Prevention of cardiotoxicity in adjuvant breast cancer (BC) therapy

被引:0
作者
Tomassi, O. M. [1 ]
Giovinazzo, P. [2 ]
Barro, S. [2 ]
Milani, L. [2 ]
Bernardi, D. [3 ]
机构
[1] ULSS 10 Veneto Orientale, San Dona Di Piave, VE, Italy
[2] ULSS 10 Veneto Orientale, Cardiol, San Dona Di Piave, VE, Italy
[3] ULSS 10 Veneto Orientale, Oncol, San Dona Di Piave, VE, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A50
引用
收藏
页码:18 / 18
页数:1
相关论文
共 50 条
[31]   Cardiotoxicity associated with cancer therapy: Pathophysiology and prevention strategies [J].
Adao, Rui ;
de Keulenaer, Gilles ;
Leite-Moreira, Adelino ;
Bras-Silva, Carmen .
REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (05) :395-409
[32]   Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guideline update: adjuvant therapy for triple negative breast cancer in 2022 [J].
Ding, Hua ;
Zhang, Li ;
Wang, Yue ;
Liu, Shu .
TRANSLATIONAL BREAST CANCER RESEARCH, 2022, 3
[33]   Cardiotoxicity Risks of Adjuvant Trastuzumab in Asian Breast Cancer Patients. [J].
Shih, V. ;
Chan, A. ;
Sim, M. H. ;
Teo, C. ;
Chen, W. ;
Wong, Z. W. .
CANCER RESEARCH, 2011, 71
[34]   Irreversible cardiotoxicity after adjuvant treatment with trastuzumab in a case of breast cancer [J].
Bordin, Paolo ;
Volpe, Carla ;
Adami, Gianna ;
Moretti, Valentino ;
Ermacora, Paola .
TUMORI, 2008, 94 (05) :777-778
[35]   Adjuvant therapy of breast cancer - Introduction [J].
Pierce, LJ .
SEMINARS IN RADIATION ONCOLOGY, 1999, 9 (03) :215-216
[36]   COMPLIANCE IN ADJUVANT BREAST CANCER THERAPY [J].
Vetter, M. ;
Schmid, S. ;
Kilic, N. ;
Rochlitz, C. ;
Gueth, U. .
ANNALS OF ONCOLOGY, 2012, 23 :15-15
[37]   ADJUVANT THERAPY OF BREAST-CANCER [J].
SHAPIRO, CL ;
HENDERSON, IC .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1994, 8 (01) :213-231
[38]   Adjuvant Endocrine Therapy for Breast Cancer [J].
Rao, Ruta D. ;
Cobleigh, Melody A. .
ONCOLOGY-NEW YORK, 2012, 26 (06) :541-559
[39]   Systemic adjuvant therapy of breast cancer [J].
Garrett, TJ ;
Vahdat, LT ;
Kinne, DW .
JOURNAL OF SURGICAL ONCOLOGY, 1997, 64 (02) :167-172
[40]   Epirubicin as adjuvant therapy for breast cancer [J].
Suh, C .
CANCER PRACTICE, 2001, 9 (02) :104-106